Inhibitory effects of N,N,N-trimethyl phytosphingosine-iodide on melanogenesis via ERK activation-mediated MITF degradation

References

• Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J. 1991;5:2902–2909.
   PubMed Web of Science ®Google Scholar
• Bellei B, Maresca V, Flori E, Pitisci A, Larue L, Picardo M. p38 regulates pigmentation via proteasomal degradation of tyrosinase. J. Biol. Chem. 2010;285:7288–7299.10.1074/jbc.M109.070573
   PubMed Web of Science ®Google Scholar
• D'Orazio J, Fisher DE. Central role for cAMP signaling in pigmentation and UV resistance. Cell Cycle. 2011;10:8–9.10.4161/cc.10.1.14292
   PubMed Web of Science ®Google Scholar
• Schiaffino MV. Signaling pathways in melanosome biogenesis and pathology. Int. J. Biochem. Cell Biol. 2010;42:1094–1104.10.1016/j.biocel.2010.03.023
   PubMed Web of Science ®Google Scholar
• Oka M, Nagai H, Ando H, et al. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J. Invest. Dermatol. 2000;115:699–703.10.1046/j.1523-1747.2000.00095.x
   PubMed Web of Science ®Google Scholar
• Kim DS, Hwang ES, Lee JE, Kim SY, Kwon SB, Park KC. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation. J. Cell Sci. 2003;116:1699–1706.10.1242/jcs.00366
   PubMed Web of Science ®Google Scholar
• Levy C, Khaled M, Fisher DE. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 2006;12:406–414.10.1016/j.molmed.2006.07.008
   PubMed Web of Science ®Google Scholar
• Jo SY, Kim HC, Woo SW, Seo MJ, Lee G, Kim HR. Synthesis of 1-substituted-phytosphingosine, novel protection of phytosphingosine. Bull. Korean Chem. Soc. 2003;24:267–268.
   Web of Science ®Google Scholar
• Park MT, Kang JA, Choi JA, et al. Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells. Clin. Cancer Res. 2003;9:878–885.
   PubMed Web of Science ®Google Scholar
• Park MT, Choi JA, Kim MJ, et al. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J. Biol. Chem. 2003;278:50624–50634.10.1074/jbc.M309011200
   PubMed Web of Science ®Google Scholar
• Song CK, Lee JH, Jahn A, et al. In vitro and in vivo evaluation of N, N, N-trimethylphytosphingosine-iodide (TMP) in liposomes for the treatment of angiogenesis and metastasis. Int. J. Pharm. 2012;434:191–198.10.1016/j.ijpharm.2012.05.042
   PubMed Web of Science ®Google Scholar
• Curto EV, Kwong C, Hermersdörfer H, et al. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem. Pharmacol. 1999;57:663–672.10.1016/S0006-2952(98)00340-2
   PubMed Web of Science ®Google Scholar
• Busca R, Bertolotto C, Ortonne JP, Ballotti R. Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J. Biol. Chem. 1996;271:31824–31830.10.1074/jbc.271.50.31824
   PubMed Web of Science ®Google Scholar
• Winder AJ. A stopped spectrophotometric assay for the dopa oxidase activity of tyrosinase. J. Biochem. Biophys. Methods. 1994;28:173–183.10.1016/0165-022X(94)90014-0
   PubMedGoogle Scholar
• Park HY, Russakovsky V, Ohno S, Gilchrest BA. The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J. Biol. Chem. 1993;268:11742–11749.
   PubMed Web of Science ®Google Scholar
• Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA. Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J. Biol. Chem. 1999;274:16470–16478.10.1074/jbc.274.23.16470
   PubMed Web of Science ®Google Scholar
• Spiegel S, Merrill AH Jr. Sphingolipid metabolism and cell growth regulation. FASEB J. 1996;10:1388–1397.
   PubMed Web of Science ®Google Scholar
• Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer. 2004;4:604–616.10.1038/nrc1411
   PubMed Web of Science ®Google Scholar
• Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996;381:800–803.10.1038/381800a0
   PubMed Web of Science ®Google Scholar
• Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 1989;243:500–507.10.1126/science.2643164
   PubMed Web of Science ®Google Scholar
• Endo K, Igarashi Y, Nisar M, Zhou Q, Hakomori S. Cell membrane signaling as target in cancer therapy: inhibitory effect of N, N-dimethyl and N, N, N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res. 1991;51:1613–1618.
   PubMed Web of Science ®Google Scholar
• Park SR, Cho HJ, Moon KJ, et al. Cytotoxic effects of novel phytosphingosine derivatives, including N, N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60. Leuk. Lymphoma. 2010;51:132–145.10.3109/10428190903383419
   PubMed Web of Science ®Google Scholar
• Kim S, Hong I, Hwang JS, et al. Phytosphigosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Mol. Med. 2006;12:17–24.
   PubMed Web of Science ®Google Scholar
• Kim DS, Park SH, Kwon SB, et al. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. Pigment Cell Res. 2006;19:146–153.10.1111/pcr.2006.19.issue-2
   PubMedGoogle Scholar
• Kim DS, Hwang ES, Lee JE, Kim SY, Park KC. Sphingosine-1-phosphate promotes mouse melanocyte survival via ERK and Akt activation. Cell Signal. 2003;15:919–926.10.1016/S0898-6568(03)00055-X
   PubMed Web of Science ®Google Scholar
• Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z. Liposomes as in vivo carriers of adriamycin:reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 1982;42:4734–4739.
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim SY, Chung JH, Kim KH, Eun HC, Park KC. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 2002;14:779–785.10.1016/S0898-6568(02)00024-4
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee SH, Shin JS, et al. A derivative of imidazobenzimidazole, ML106, inhibits melanin synthesis via p38 MAPK activation. Pharmazie. 2014;69:353–357.
   PubMed Web of Science ®Google Scholar
• Baek SH, Lee SH, Sesamol decreases melanin biosynthesis in melanocyte cells and zebrafish: Possible involvement of MITF via the intracellular cAMP and p38/JNK signaling pathways, Exp. Dermatol. 2015; E-pub ahead of print. doi: 10.1111/exd.12765.
   Web of Science ®Google Scholar
• Wu H, Park HY. Protein kinase C-beta-mediated complex formation between tyrosinase and TRP-1. Biochem. Biophys. Res. Commun. 2003;311:948–953.10.1016/j.bbrc.2003.10.092
   PubMed Web of Science ®Google Scholar